Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Fintel reports that on November 6, 2024, Bernstein initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Susan Morrison; Executive Vice President, Chief Administrative Officer; Tandem Diabetes Care Inc John Sheridan; President, Chief Executive Officer, Director; Tandem Diabetes Care Inc Leigh Vosseller; ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective lowered by Canaccord Genuity Group from $57.00 to ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Today is world Diabetes day. According to Diabetes UK, 4.4 million people are currently living with Diabetes in the ...

Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today ...

Sales: In the United States, GAAP sales included $1.0 million incremental sales relating to Tandem Choice compared to a sales deferral of $8.2 million. Non-GAAP sales exclude Tandem Choice-related ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...